• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Pulmonary Hypertension

Pulmonary Hypertension

9780199572564
365.04 zł
328.54 zł Save 36.50 zł Tax included
Lowest price within 30 days before promotion: 328.54 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
High pressure in the lungs, or pulmonary hypertension, is most commonly due to smoking-related lung disease and conditions affecting the left heart, for example, high blood pressure in the arteries, faulty heart valves, and a weakened heart muscle. Pulmonary arterial hypertension (PAH), is a rare and complex disease, associated with many different medical conditions, which is caused by a growth of cells lining the inside of the lung arteries, resulting in high pressure in areas ofthe body. Both conditions lead to strain and potential failure of the right heart, and therefore awareness and early diagnosis of the condition is needed to lead to better outcomes:: however this depends on education of all specialists and primary care clinicians about PAH. This practical handbook covers both PH and PAH, providing information required by the wide range of clinicians who will encounter these conditions, including cardiologists, respiratory physicians, rheumatologists, specialists in liver and AIDS medicine, and haematologists. It covers what it is, who it is likely to affect, how it is diagnosed, including the pitfalls of the various diagnostic tests, the different and evolving forms of treatment, long term management of this often devastatingchronic disease, and the crucial role of multidisciplinary management in optimizing clinical care of these patients who usually have multi-system diseases. It also covers the up new classification for both PH and PAH, and new drugs that have recently become available.
Product Details
OUP Oxford
87096
9780199572564
9780199572564

Data sheet

Publication date
2012
Issue number
1
Cover
paperback
Pages count
264
Dimensions (mm)
100 x 180
Weight (g)
132
  • History of pulmonary hypertension and the circulation; Definitions of pulmonary hypertension and pulmonary arterial hypertension; Clinical classification of pulmonary hyptertension; Pathology of pulmonary hyptertension; Pathology of chronic thromboembolic pulmonary hypertension; Pathobiology of pulmonary arterial hypertension; Inflammation, growth factors and thrombosis in pulmonary arterial hypertension; Genetics and genomics of pulmonary arterial hypertension; Epidemiology of pulmonary arterial hypertension and pulmonary hypertension; Risk factors for pulmonary arterial hypertension; Pathophysiology of pulmonary hypertension in non-pulmonary arterial hypertension groups; Pulmonary arterial hypertension associated with connective tissue diseases; Systemic sclerosis; Systemic lupus erythematosus; Sjögrens syndrome; Polymyositis and dermatomyositis; HIV; Porto-pulmonary hypertension; Venous thromboembolism and acute pulmonary embolism; Acute pulmonary embolism; Chronic thromboembolic pulmonary hypertension; Pulmonary hypertension associated with congenital systemic-to-pulmonary cardiac shunts; Schistomiasis; Chronic haemolytic anaemias and pulmonary arterial hypertension; Interstitial lung disease and pulmonary hypertension; Prognosis of pulmonary arterial hypertension; The right ventricle; Clinical features of pulmonary arterial hypertension; Haemodynamics and treatment approaches in pulmonary hypertension due to left heart disease; Diagnostic algorithm; Simple investigations; Ventilation/perfusion scanning; Echocardiography; Non-invasive exercise testing; Cardiac catheterisation; Management of pulmonary arterial hypertension; General measures; Contraception in pulmonary arterial hypertension; Risks of pregnancy and contraception; Lifestyle issues; Elective surgery in patients with pulmonary arterial hypertension; Supportive therapy; Management of arrhythmias; Advanced therapies for pulmonary arterial hypertension; Endothelin and endothelin receptor antagonists; Phosphodiesterase-5 inhibitors; Classes of recommendations for procedures and treatments; Drug interactions with pulmonary arterial hypertension targeted therapies; Combination therapy in pulmonary arterial hypertension; Problems in conducting pulmonary arterial hypertension drug trials; Atrial septostomy; Translation;
Comments (0)